Raverot, Gérald 1971-...
Gérald Raverot
Raverot, Gérald
VIAF ID: 37144170 (Personal)
Permalink: http://viaf.org/viaf/37144170
Preferred Forms
- 100 0 _ ‡a Gérald Raverot
-
-
- 100 1 _ ‡a Raverot, Gérald
- 100 1 _ ‡a Raverot, Gérald, ‡d 1971-....
- 100 1 _ ‡a Raverot, Gérald ‡d 1971-...
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Adult craniopharyngiomas, 2020: | |
Aggressive prolactinomas: how to manage? | |
Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomide | |
Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up | |
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. | |
Biological and radiological exploration and management of non-functioning pituitary adenoma. | |
Cabergoline therapy of paraneoplastic Cushing syndrome in children | |
Centralization errors in comparative genomic hybridization array analysis of pituitary tumor samples. | |
Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases | |
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study | |
Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease. | |
Déficits hypophysaires secondaires à un traumatisme crânien : histoire naturelle, conséquences métaboliques et neurocognitives à 18 mois | |
Développement et caractérisation de nouveaux modèles précliniques in-vivo et in-vitro permettant l'étude des tumeurs hypophysaires gonadotropes | |
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors | |
Dramatic change in skin color after bilateral adrenalectomy in Cushing's disease | |
Dysregulation of cell cycle in animal models and human neuroendocrine pituitary tumors (PitNET). | |
Endocrinologie, diabétologie et maladies métaboliques | |
Endocrinologie, métabolisme examen national classant, 2e cycle des études médicales | |
Évaluation de l'efficacité et des risques de la chirurgie hypophysaire endoscopique transsphenoidale comme traitement de première intention des prolactinomes | |
Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR®): A French Observational Study | |
Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal | |
Expression et fonction de Sox3 : du développement gonadique au contrôle de l'initiation de la spermatogenèse : étude d'un modèle de souris Sox3 KO et application à l'infertilité chez l'homme | |
Expression immuno-histochimique du récepteur Alfa aux oestrogènes dans 95 adénomes gonadotropes | |
Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth. | |
Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies | |
Facteurs prédictifs de l'expression de SSTR5 dans les adénomes hypophysaires corticotropes fonctionnels et silencieux = Predictive factors of SSTR5 expression in functionning and silent corticotroph pituitary neuro-endocrine tumors | |
Facteurs pronostiques de rémission post-opératoire précoce dans l'acromégalie : à propos d'une série de 63 patients | |
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal | |
Genomic alterations in pituitary tumors : identification of candidate genes associated with tumorigenesis and prognosis. | |
Giant prolactinomas in women | |
Gonadotroph Tumors Show Subtype Differences That Might Have Implications for Therapy | |
HMGA1-pseudogene expression is induced in human pituitary tumors. | |
Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients. | |
Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature | |
Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women | |
Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors. | |
L'apoplexie hypophysaire : histoire d'une céphalée peu ordinaire (à propos d'un cas clinique avec revue de la littérature) | |
L'insuffisance hypophysaire post-traumatique : étude prospective lyonnaise | |
La macroprolactinémie : diagnostic biologique, caractérisation clinique et radiologique | |
Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients | |
The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications | |
Mir-23b and miR-130b expression is downregulated in pituitary adenomas | |
Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans. | |
Molecular mechanisms of pituitary adenoma tumorigenesis and invasiveness. | |
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. | |
New targeted therapies in pituitary carcinoma resistant to temozolomide | |
Non-functioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic. | |
Nuclear receptors Sf1 and Dax1 function cooperatively to mediate somatic cell differentiation during testis development | |
An old retrocardiac mass fortuitously reclassified as paraganglioma | |
Pasireotide: A potential therapeutic alternative for resistant prolactinoma | |
Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment | |
Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature. | |
Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences. | |
Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification | |
Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography | |
Prognostic factors of regrowth in nonfunctioning pituitary tumors. | |
Proliferation markers of human pituitary tumors: contribution of a genome-wide transcriptome approach. | |
Reconsidering olfactory bulb magnetic resonance patterns in Kallmann syndrome. | |
Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification | |
Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade. | |
Rôle de la prolactine dans la tumorigenèse du prolactinome | |
Rôle des oncoprotéines Maf dans les cellules endocrines anté-hypophysaires | |
Le rôle essentiel du traitement conservateur dans la prise en charge de l'apoplexie hypophysaire = A key role for conservative treatment in the management of pituitary apoplexy | |
Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma | |
Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability | |
Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study | |
Silent GH pituitary tumor: diagnostic and therapeutic challenges | |
Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature. | |
Sox3 Is Required for Gonadal Function, but Not Sex Determination, in Males and Females | |
Surrénalectomie bilatérale chez les patients présentant un syndrome de Cushing : étude sur la qualité de vie | |
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly | |
Transdifferentiation of Neuroendocrine Cells: Gangliocytoma Associated With Two Pituitary Adenomas of Different Lineage in MEN1. | |
Treatment of aggressive pituitary tumours and carcinomas: Results of a European Society of Endocrinology (ESE) survey 2016. | |
Triple-A syndrome: a wide spectrum of adrenal dysfunction. | |
Tumeurs neuroendocrines gastroentéropancréatiques : recherche de nouveaux mécanismes de progression tumorale et de nouvelles cibles thérapeutiques | |
Tumorigenèse, progression tumorale et zonation fonctionnelle du cortex surrénalien | |
Unusual neurologic presentation of aseptic abscesses syndrome. | |
X-linked sex-determining region Y box 3 (SOX3) gene mutations are uncommon in men with idiopathic oligoazoospermic infertility |